High-precision atomic mass measurements at the Accelerator Laboratory of the University of Jyväskylä, Finland, have revealed that beta decay of the silver-110 isomer has a strong potential to be ...

Clarity inks multi-year copper-64 supply deal with Nusano Nusano’s facility supports large-scale isotope production Agreement strengthens pipeline for oncology diagnostics and therapies Clarity ...

Nusano's 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected to begin production in 2025 with copper-64 isotope supply planned to commence in early 2026.

Clarity Pharmaceuticals (ASX:CU6), a clinical-stage radiopharmaceutical company focused on next-generation cancer treatments, has announced a commercial-scale supply agreement for copper-64 with ...